Monday, November 26, 2012

Deadly Grapefruit-Drug Interactions Soar

Health Stories  
Deadly Grapefruit-Drug Interactions Soar
Monday, November 26, 2012 4:36 PM
Print this Page  
Forward Page  Forward Page
Email Us  Email Us
Share

According to the report, drugs that can interact with grapefruit include:
Certain cholesterol-lowering statin drugs, such as Zocor (simvastatin), Lipitor (atorvastatin) and Pravachol (pravastatin), 

Some blood pressure-lowering drugs, such as nifedipine (Nifediac and Afeditab),
Organ transplant rejection drugs, such as cyclosporine (Sandimmune and Neoral),
Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban.


Read more: Deadly Grapefruit-Drug Interactions Soar

Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban.

Read more: Deadly Grapefruit-Drug Interactions Soar
Some blood pressure-lowering drugs, such as nifedipine (Nifediac and Afeditab),
Organ transplant rejection drugs, such as cyclosporine (Sandimmune and Neoral),
Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban.


Read more: Deadly Grapefruit-Drug Interactions Soar


Read more: Deadly Grapefruit-Drug Interactions Soar

According to the report, drugs that can interact with grapefruit include:
Certain cholesterol-lowering statin drugs, such as Zocor (simvastatin), Lipitor (atorvastatin) and Pravachol (pravastatin),
Some blood pressure-lowering drugs, such as nifedipine (Nifediac and Afeditab),
Organ transplant rejection drugs, such as cyclosporine (Sandimmune and Neoral),
Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban.


Read more: Deadly Grapefruit-Drug Interactions Soar
According to the report, drugs that can interact with grapefruit include:
Certain cholesterol-lowering statin drugs, such as Zocor (simvastatin), Lipitor (atorvastatin) and Pravachol (pravastatin),
Some blood pressure-lowering drugs, such as nifedipine (Nifediac and Afeditab),
Organ transplant rejection drugs, such as cyclosporine (Sandimmune and Neoral),
Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban.


Read more: Deadly Grapefruit-Drug Interactions Soar
According to the report, drugs that can interact with grapefruit include:
Certain cholesterol-lowering statin drugs, such as Zocor (simvastatin), Lipitor (atorvastatin) and Pravachol (pravastatin),
Some blood pressure-lowering drugs, such as nifedipine (Nifediac and Afeditab),
Organ transplant rejection drugs, such as cyclosporine (Sandimmune and Neoral),
Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban.


Read more: Deadly Grapefruit-Drug Interactions Soar
According to the report, drugs that can interact with grapefruit include:
Certain cholesterol-lowering statin drugs, such as Zocor (simvastatin), Lipitor (atorvastatin) and Pravachol (pravastatin),
Some blood pressure-lowering drugs, such as nifedipine (Nifediac and Afeditab),
Organ transplant rejection drugs, such as cyclosporine (Sandimmune and Neoral),
Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban.


Read more: Deadly Grapefruit-Drug Interactions Soar

Monday, November 19, 2012

Nose cell transplant enables paralysed dogs to walk

Nose cell transplant enables paralysed dogs to walk

Jasper the dachshund walking again

Related Stories

Scientists have reversed paralysis in dogs after injecting them with cells grown from the lining of their nose.
The pets had all suffered spinal injuries which prevented them from using their back legs.
The Cambridge University team is cautiously optimistic the technique could eventually have a role in the treatment of human patients.
The study is the first to test the transplant in "real-life" injuries rather than laboratory animals.

Olfactory ensheathing cells

The only part of the body where nerve fibres continue to grow in adults is the olfactory system.
Found in the at the back of the nasal cavity, olfactory ensheathing cells (OEC) surround the receptor neurons that both enable us to smell and convey these signals to the brain.
The nerve cells need constant replacement which is promoted by the OECs.
For decades scientists have thought OECs might be useful in spinal cord repair. Initial trials using OECs in humans have suggested the procedure is safe.

Wednesday, November 14, 2012

Meditation may reduce risk of dying from heart attack, strokes

Transcendental Meditation may help black people with heart disease avoid an early death from heart attack or stroke, new research shows.

"It appears that Transcendental Meditation is a technique that turns on the body's own pharmacy -- to repair and maintain itself," study author Dr. Robert Schneider, director of the Institute for Natural Medicine and Prevention in Fairfield, Iowa and dean of Maharishi College of Perfect Health, said in a press release.

The study was published in the Nov. 13 issue of the journal Circulation: Cardiovascular Quality and Outcomes.

WebMD has more information on Transcendental Meditation.

http://www.cbsnews.com/8301-204_162-57549923/meditation-may-reduce-risk-of-dying-from-heart-attack-strokes/

Thursday, November 8, 2012

Black Tea Lowers Type 2 Diabetes Risk .

In countries where people commonly drink black tea, the rates of Type 2 diabetes are lower, according to a new study. The new research supports earlier studies that suggests that drinking black tea regularly reduces the risk of diabetes.

 Black tea contains a number of complex flavonoids that have been linked with several potential health benefits, the researchers noted. The brewing process releases these flavonoids.

Tuesday, November 6, 2012

Donated Stem Cells Can Repair Hearts

Researchers are reporting a key advance in using stem cells to repair hearts damaged by heart attacks. In a study, stem cells donated by strangers proved as safe and effective as patients' own cells for helping restore heart tissue.

About a year later, scar tissue had been reduced by about one-third. Both groups had improvements in how far they could walk and in quality of life. There was no significant difference in one measure of how well their hearts were able to pump blood, but doctors hope these patients will continue to improve over time, or that refinements in treatment will lead to better results.